Biotech news
Americas
How can innovators secure reliable protection across diagnostics, genetics, and AI-integrated devices while navigating Section 101 and 112 pitfalls? This comprehensive panel addresses strategies to clear fundamental patentability hurdles amid shifting court decisions and USPTO guidelines. 22 May 2026
Americas
The rapid evolution of CRISPR and base editing brings transformative medical potential alongside deeply complex IP and licensing hurdles. This session explores how companies can balance innovation with risk mitigation in a crowded and highly contested precision medicine landscape. 21 May 2026
Americas
The influx of biosimilars and generics requires innovator companies and challengers alike to continually refine their litigation tactics. This panel dissects current trends in Hatch-Waxman and BPCIA frameworks, providing a roadmap for defending franchises and navigating market entry. 20 May 2026
Americas
Success in complex pharmaceutical litigation often comes down to early preparation and cross-functional alignment. This session explores how companies can proactively manage Hatch-Waxman and BPCIA disputes through strategic front-end planning and operational execution. 19 May 2026
Europe
Are the EPO and the UPC diverging in their assessment of inventive step? By analysing key recent pharmaceutical decisions, this presentation highlights potential differences in standards and considers how they impact European patent strategies. 18 May 2026
Americas
The intersection of regulatory strategy and intellectual property protection has become critical to maintaining market exclusivity. This panel examines how life sciences companies can adapt their IP strategies in response to shifting FDA guidance, biosimilar challenges, and evolving agency priorities. 17 May 2026
Biotech
As antibodies cement their status as a major therapeutic class, securing robust IP protection has grown increasingly difficult. With heightened scrutiny on enablement and written description requirements, this panel unpacks strategies for building resilient antibody portfolios in a challenging global landscape. 16 May 2026
Regulation & Industry
Are life sciences cases gaining momentum in the new Unified Patent Court? This session provides a critical update on the UPC's evolving jurisprudence, looking at emerging legal tests and the specific challenges of preliminary injunctions for life sciences products. 14 May 2026
Americas
PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices. 13 May 2026
Americas
The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion. 12 May 2026